MedTrace Logo

AirSense 10 AHI Validation Study

NCT03043703 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-03-28

No results posted yet for this study

Summary

The AirSense 10 platform is able to detect respiratory events at night and report these data via telemonitoring. The accuracy of the AirSense 10 will be compared with scoring with polysomnography (PSG). 100 patients will be observed in a sleep facility under PSG and AirSense treatment.

Conditions

Interventions

DEVICE

AirSense 10 AutoSet for Her

Positive airway pressure

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Volker Toepfer, Dr · Lungenzentrum Ulm

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2020-03-31
Completion
2020-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043703 on ClinicalTrials.gov